SEC EDGAR · Company announcement
LRMR: Financial results · Other company developments
Filed 8-K for an event or period dated 2026-11-09. Financial results; Other company developments.
Follow LRMR- Became public
- Nov 9, 2026, 4:08 PM EST
- Event / period date
- Nov 9, 2026
- Collected
- Nov 16, 2026, 7:26 AM EST
Why this is connected
This filing identifies Larimar Therapeutics, Inc. as the issuer of the security. The company's SEC identifier connects it to LRMR.
Press Release of Larimar Therapeutics, Inc., dated November 9, 2026* ↗Source evidence
Read the source excerpt or record
Item 2.02 Results of Operations and Financial Condition. On November 9, 2026, Larimar Therapeutics, Inc. (the “Company”) disclosed in an updated slide presentation, posted on its website, that, as of September 30, 2026, the Company had approximately $128.7 million of cash, cash equivalents and marketable securities. The Company has not yet completed its quarter-end financial close processes for the quarter ended September 30, 2026. The review of the Company’s financial statements for the quarter ended September 30, 2026 is ongoing and could result in changes to this amount. This estimate of the Company’s cash, cash equivalents and marketable securities as of September 30, 2026 is preliminary, has not been audited, does not present all information necessary for an understanding of the Company’s financial condition as of September 30, 2026 and is subject to change upon completion of the Company’s financial statement closing procedures. The preliminary financial data included in this Current Report on Form 8-K has been prepared by, and is the responsibility of, the Company’s management. Additional information and disclosure would be required for a more complete understanding of the Company’s financial position and results of operations as of September 30, 2026. The information furnished pursuant to this Item 2.02 is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing. Item 8.01 Other Events. Press Release On November 9,
Price change after we could observe it
+7.69% LRMR
Adjusted closing prices from Nov 17, 2026 to Nov 19, 2026. SPY changed -1.70% over the same dates. The start is the first available close after both publication and collection. This is a price comparison, not an executed trade, investor profit, or a backtested strategy.
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.